1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > Global Hospital-acquired Disease Testing Market 2015-2019

Global Hospital-acquired Disease Testing Market 2015-2019

  • July 2015
  • -
  • Infiniti Research Limited
  • -
  • 92 pages

Summary

Table of Contents

Search Inside

About Hospital-acquired Diseases
Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and gastrointestinal illnesses. These infections appear between 48 hours and four days after a patient is admitted and are usually related to a treatment of procedure used to treat or diagnose the patient's initial illness or injury. Hospital-acquired diseases are preventable through adherence to strict guidelines and less usage of invasive equipment that must be followed by healthcare professionals while caring for the patient.
Technavio's analysts forecast the global hospital-acquired disease testing market to grow at a CAGR of 19.44% over the period 2014-2019.

Covered in this Report
In this report, Technavio covers the present scenario and the growth prospects of the global hospital-acquired disease testing market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of testing products used in the following hospital-acquired disease infections: SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and others.
Technavio's report, Global Hospital-acquired Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hospital-acquired disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
- Americas
- APAC
- EMEA
Key Vendors
- Abbott Laboratories
- Becton and Dickenson
- bioMerieux
- Roche Diagnostics
Other Prominent Vendor
- Akers Biosciences
- Alere
- Beckman Coulter/Danaher
- Cantel Medical
- Cepheid
- Diatherix Laboratories
- Eiken Chemical
- Enzo Biochem
- Fujirebio/Innogenetics
- Gen-Probe
- Humor Diagnostica
- Life Technologies
- Meridian Bioscience
- Nordion
- QIAGEN
Market Driver
- Rising Prevalence of HAIs
- For a full, detailed list, view our report
Market Challenge
- Lack of Healthcare Infrastructure
- For a full, detailed list, view our report
Market Trend
- Technological Advancements
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017-2021 US Ancillary Hospital Locations (ER, OR, ICU, CCU) Diagnostics Market--Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017-2021 US Ancillary Hospital Locations (ER, OR, ICU, CCU) Diagnostics Market--Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2017-2021 US Critical Care Diagnostics Market in Ancillary Hospital Locations (ERs, ORs, ICU/CCUs): Test Volume and Sales Segment Forecasts, Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

2017-2021 US Critical Care Diagnostics Market in Ancillary Hospital Locations (ERs, ORs, ICU/CCUs): Test Volume and Sales Segment Forecasts, Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of ...

2017 US Hematology and Flow Cytometry Market: Hospitals, Commercial Laboratories, POC Locations

2017 US Hematology and Flow Cytometry Market: Hospitals, Commercial Laboratories, POC Locations

  • $ 7500
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.